Clinical Report: AI May Predict PGL Gene Cluster
Overview
An AI-based analysis of reticulin architecture can predict molecular cluster status in paragangliomas (PGLs). The study found significant correlations between histoarchitectural features and underlying germline genotypes, particularly distinguishing between cluster 1 and cluster 2 tumors.
Background
Pheochromocytomas and extra-adrenal paragangliomas are neuroendocrine tumors with a high prevalence of heritable mutations. Molecular classification of these tumors into distinct clusters is crucial for understanding their biological behavior and guiding clinical management. Accurate prediction of tumor genotype can enhance personalized treatment strategies and genetic counseling.
Data Highlights
| Finding | Cluster 1 | Cluster 2 | Sporadic |
|---|---|---|---|
| Intact reticulin presence | 85% | ~30% | ~30% |
| Very small nests median area | 35.2% | 7.3% | 9.4% |
| Median intact reticulin area | 53% | ~30% | ~30% |
Key Findings
- 39 patients (37.5%) had germline mutations, with 20 in cluster 1 and 19 in cluster 2.
- Intact reticulin was significantly more frequent in cluster 1 tumors (85%) compared to cluster 2 and sporadic tumors.
- Very small nests were significantly enriched in cluster 1 tumors (p=0.003).
- The AI model achieved high precision and sensitivity in predicting cluster 1 genotype based on reticulin metrics.
- Younger age, larger tumor size, and extra-adrenal location correlated with increased probability of cluster 1 genotype.
Clinical Implications
Routine reticulin staining can provide valuable morphological insights for evaluating PGLs, potentially guiding genetic counseling and testing. AI-assisted morphometrics may standardize assessments and enhance diagnostic workflows, especially in resource-limited settings.
Conclusion
The integration of AI in histopathological evaluation of PGLs offers promising avenues for improving diagnostic accuracy and personalizing patient care. Further validation is necessary before clinical implementation.
References
- Duregon E., et al., Endocrine Pathology, 2023 -- AI May Predict PGL Gene Cluster
- Journal of Neuro-Oncology — Regulation of PRC2 Components by Polycomb-like 2 Influences Glioma Cell Proliferation
- Blood Cancer Journal — Meta-analysis Across the Genome Reveals Risk Loci Associated with Monoclonal Gammopathy of Undetermined Significance (MGUS) and IRF-6 Impact
- Ophthalmology Management — Genetic Predisposition to Glaucoma
- Acta Neuropathologica — Comprehensive Analysis of Genetic, Epigenetic, and Pathological Factors in Paraganglioma Uncovers Complex Dysregulation of NOTCH Signaling
- Pheochromocytoma and Paraganglioma - Endotext - NCBI Bookshelf
- Pheochromocytoma and Paraganglioma - Endotext - NCBI Bookshelf
- FDA approves belzutifan for pheochromocytoma or paraganglioma | FDA
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
